Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Accounts Payable, Accrued Liabilities and Other

v3.8.0.1
Note 9 - Accounts Payable, Accrued Liabilities and Other
 9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
9
.
Accounts Payable
, Accrued Liabilities and Other
 
Accounts payable at
September 30, 2017
and
December 31, 2016
includes an aggregate of
$0
and
$116,000,
respectively, due to related parties related to director fees and MT scientific advisory board fees. At
September 30, 2017,
approximately
$96,000
of accounts payable is being disputed by the Company related to legal fees associated with unauthorized expenditures by a former executive, which were incurred during the year ended
December 31, 2016.
 
Accrued liabilities and other at
September 30, 2017
includes
$64,000
due to related parties for director fees. Accrued liabilities and other at
December 31, 2016
includes an aggregate of
$106,000
due to related parties for executive bonuses, director fees, deferred salary owed to Dr. Goldberg, and MT scientific advisory board fees.